BIO: FDA draft report on biotech salmon is a step forward

An FDA draft evaluation on the safety of AquaBounty Technology's transgenic salmon is a good sign, said David Edwards, BIO's director of animal biotechnology. "It certainly looks good for the fish moving forward," Edwards said. "It shows that the Obama administration is willing to move forward on these technologies and allow the United States to be the leader that we should be."

View Full Article in:

United Press International · Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Medical Director - Cataract
Santa Ana, CA